Striving to provide the very best product to our customers means Väsamed must hire and develop the very best employees. This commitment works from the top down. We are proud of our experienced and dedicated management team. They have acquired decades of trade and industry experience which translates into better leaders and corporate structure to develop and market our products.

Paulita M. LaPlante - President and a Director of Väsamed since September 1998 and Chief Executive Officer since December 1998. From June 1994 to September 1998, Ms. LaPlante served as Väsamed’s Vice President of Worldwide Sales, Marketing and Business Development and was Director of Marketing and Business Development from April 1992 to June 1994. She also served as Väsamed’s interim Vice President of Research and Development from January 1994 to September 1994. Ms. LaPlante served on the board of VidaMed, Inc. from November 1999 to August 2002 and on the board of Compex Rehabilicare from May 2005 to January 2006. Ms. LaPlante currently serves on the board of Qualigen, Inc.

Daniel J. Bartnik - Chief Technology Officer/Vice President of Operations.
Mr. Bartnik has over twenty years of product development experience. At Väsamed since 1991, Mr. Bartnik has developed and advanced technologies for noninvasive and minimally invasive measurement of various physiologic parameters and developed a team of individuals to support these efforts. Mr. Bartnik worked for Unisys Defense Systems (1984 to 1991) in advanced optical research and development, advanced signal processing, and embedded computer development. He developed software to perform statistical analysis when he worked for the Finnish Forest Research Institute (1983).   Mr. Bartnik holds a B.S. degree in Electrical and Computer Engineering from the University of Wisconsin and a M.S. degree in Electrical Engineering from the University of Minnesota.

John Campbell - Vice President of Sales & Marketing. Mr. Campbell has over twenty years of sales and marketing experience within the medical market. In his career John has had US and global responsibilities for pharmaceutical, medical equipment and cardiovascular device technologies. His experience includes building a US sales and marketing organization to commercialize the ACIST endovascular equipment and disposable products to vascular interventional labs in the US market. Within two years of launch, revenues were built to $11MM which resulted in the acquisition of the company. He also led the commercialization of the embolic protection and peripheral stent technologies for ev3 Inc.